Clincosm LogoSign in Get a demo

gastric cancer stage iv

Showing 1 - 10 of 10
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tislelizumab Combined With Chemotherapy in First-line Treatment

Active, not recruiting
  • Tislelizumab
  • +3 more
  • Beijing, China
    Cancer Institute and Hospital, Chinese Academy of Medical Scienc
Sep 6, 2023

Gastric Cancer Stage IV Trial (Oxaliplatin, Levo-Leucovorin, 5-fluorouracil)

Not yet recruiting
  • Gastric Cancer Stage IV
  • (no location specified)
Nov 13, 2022

Circulating Angiogenic Factors for Second-line Paclitaxel and

Recruiting
  • Gastric Cancer Stage IV
    • Pisa, Italy
      University of Pisa
    Mar 28, 2022

    Gastric Cancer Stage IV, Peritoneal Metastases Trial in Shanghai (sintilimab, paclitaxel and S-1)

    Recruiting
    • Gastric Cancer Stage IV
    • Peritoneal Metastases
    • sintilimab, paclitaxel and S-1
    • Shanghai, Shanghai, China
      Ruijin Hospital Shanghai Jiao Tong University School of Medicine
    Jan 10, 2022

    Gastric Cancer Stage IV Trial in Seoul (olaparib+pembrolizumab+paclitaxel)

    Not yet recruiting
    • Gastric Cancer Stage IV
    • Seoul, Korea, Republic of
      Severance Hospital
    Aug 29, 2021

    Gastric Cancer Stage IV Trial in Wuhan (Toripalimab, Docetaxel, nab-paclitaxel)

    Recruiting
    • Gastric Cancer Stage IV
    • Wuhan, Hubei, China
      Cancer Center, Union Hospital, Tongji Medical College, Huazhong
    Mar 14, 2021

    Gastric Cancer Stage IV, Peritoneal Carcinomatosis, Intraperitoneal Paclitaxel Trial in Seongnam-si (Paclitaxel, mFOLFOX6

    Recruiting
    • Gastric Cancer Stage IV
    • +3 more
    • Seongnam-si, Gyeonggi-do, Korea, Republic of
      Seoul National University Bundang Hospital
    Mar 7, 2021

    Liver Cancer Stage IV, Gastric Cancer Stage IV, Esophageal Cancer, Stage IV Trial in Guangzhou (TAEST16001)

    Completed
    • Liver Cancer Stage IV
    • +9 more
    • Guangzhou, Guang Dong, China
      Zhujiang Hospital of Southern Mediacl University
    Jan 20, 2020

    Gastric Cancer Stage IV, EBV Trial in Guangzhou (PD-1 antibody (SHR-1210))

    Unknown status
    • Gastric Cancer Stage IV
    • EBV
    • PD-1 antibody (SHR-1210)
    • Guangzhou, Guangdong, China
      Cancer center of Sun Yat-sen University
    Nov 6, 2019

    Gastric Cancer Stage IV, Cancer of Stomach Trial in Guangzhou (S-1 maintenance, Observation)

    Unknown status
    • Gastric Cancer Stage IV
    • Cancer of Stomach
    • S-1 maintenance
    • Observation
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Oct 7, 2018